Tema Oncology ETF (NQ:CANC)

40.99 -0.31 (-0.75%)

Official Closing Price Updated: 4:15 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tema Oncology ETF

Why Did GLUE Stock Surge Over 50% In Premarket Today? ↗

January 07, 2026

Monte Rosa Therapeutics reported positive interim Phase 1 data for MRT-8102, showing significant anti-inflammatory effects in patients with elevated cardiovascular risk.

Via Stocktwits

Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance

December 02, 2025

From Tema ETFs

Via Business Wire

AUTL Stock Soars Pre-market On Positive Recommendation For Cell Therapy Targeting Cancer In UK ↗

November 25, 2025

Via Stocktwits

Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market ↗

April 25, 2024

The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate.

Via Investor's Business Daily

Healthcare ETFs For The Weight-Loss Drug Boom And Beyond ↗

April 08, 2024

Two dominant investing themes over the past year have been AI and weight-loss drugs.

Via Talk Markets

Topics Artificial Intelligence ETFs

Biden's Million Dollar Moonshot - $240 Million Is A Boon For Cancer Research, Will it be a Boost For Pharma Stocks Too? ↗

December 05, 2023

Via Benzinga

EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads ↗

December 01, 2023

Tema ETFs is redefining thematic investing, focusing on long-term structural trends & precision in security selection rather than chasing short-term fads.

Via Benzinga

Topics ETFs

Active ETFs Appear Booming In 2023 — Tema ETFs Are Taking Them Into A New Direction ↗

November 28, 2023

The rapid emergence of the ETF industry, marked by its AuM growth from $1 trillion to $10 trillion this past decade, was driven by passive indexed funds which thrived in a low-rates, low-volatility...

Via Benzinga

Topics ETFs

Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF? ↗

November 21, 2023

New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,...

Via Benzinga

Topics ETFs

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.